Profil
Sean Doherty is the Founder of the T1D Fund and former Chair of the Board who led the concept-creation, design and capital financing of the Fund, and he has driven its strategy since inception..
Sean retired at the end of 2018 from his role as Managing Director of Bain Capital, LP, a private global investment firm which he joined in 2005 as the firm’s first general counsel.
In this role he built a pioneering and industry-leading deal lawyer and risk management group during a time of rapid growth and institutionalization of the alternative asset industry.
He also had a diverse operational and constituency management role at Bain Capital, where he led crisis management, press and external communications, government relations, branding and philanthropic initiatives and was deeply involved in governance matters and capital raising.
Earlier in his career he worked at Ropes & Gray LLP and was a law clerk to a federal district judge in Boston.
Prior to law school, he was a Lieutenant in the U.S.
Navy, in which he served on a Middle East Force frigate from 1990-94.
Sean and his wife, Suzy, have been involved with JDRF since 2002 when their son Finn was diagnosed with T1D at the age of 2.
He served on the JDRF International Board and its Executive Committee from 2016 to 2019 following more than a decade of service on the JDRF New England Chapter Board, including two years as its President.
He received a J.D.
magna cum laude from Harvard Law School and a B.A. magna cum laude in Government from Harvard College.
He serves on the boards of directors of two companies with T1D programs and is also a member of the board of trustees of Thayer Academy in Braintree, MA.
Postes actifs de Sean N. Doherty
| Sociétés | Poste | Début |
|---|---|---|
BC XII Private Investors (Lux) SCSP
BC XII Private Investors (Lux) SCSP Investment ManagersFinance Acts as Private Equity Fund | Directeur Général | - |
Anciens postes connus de Sean N. Doherty
| Sociétés | Poste | Fin |
|---|---|---|
| PROVENTION BIO, INC. | Directeur/Membre du Conseil | 01/01/2022 |
ImmunoMolecular Therapeutics, Inc.
ImmunoMolecular Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures immuno-therapeutic drugs for autoimmune diseases | Directeur/Membre du Conseil | 31/12/2021 |
JDRF International
JDRF International Miscellaneous Commercial ServicesCommercial Services Performs research & development on diabetes | Directeur/Membre du Conseil | 31/12/2019 |
Bain Capital LP
Bain Capital LP Financial ConglomeratesFinance Provides investment services | Conseiller Juridique Général | 31/12/2018 |
US Department of the Navy (District of Columbia)
US Department of the Navy (District of Columbia) SovereignGovernment Naval service branch of the government | Corporate Officer/Principal | 01/01/1994 |
Formation de Sean N. Doherty
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Bain Capital LP
Bain Capital LP Financial ConglomeratesFinance Provides investment services | Finance |
US Department of the Navy (District of Columbia)
US Department of the Navy (District of Columbia) SovereignGovernment Naval service branch of the government | Government |
JDRF International
JDRF International Miscellaneous Commercial ServicesCommercial Services Performs research & development on diabetes | Commercial Services |
Trustees of Thayer Academy
Trustees of Thayer Academy Miscellaneous Commercial ServicesCommercial Services Provides educational services | Commercial Services |
JDRF New England Chapter | |
Ropes & Gray LLP
Ropes & Gray LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Harvard Law School
Harvard Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard College
Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ImmunoMolecular Therapeutics, Inc.
ImmunoMolecular Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures immuno-therapeutic drugs for autoimmune diseases | Health Technology |
Provention Bio, Inc.
Provention Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company that engages in intercepting and preventing immune-mediated diseases including type 1 diabetic activities | Health Technology |
BC XII Private Investors (Lux) SCSP
BC XII Private Investors (Lux) SCSP Investment ManagersFinance Acts as Private Equity Fund | Finance |
JDRF T1D Fund
JDRF T1D Fund Investment ManagersFinance T1D Fund invests in companies located across the globe. The firm focuses on health technology sector. It participates in early stage capital requirements. | Finance |
















